##gff-version 3
##sequence-region Q00839 1 825
Q00839	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:22223895,ECO:0000244|PubMed:22814378,ECO:0000269|PubMed:7993898,ECO:0000269|Ref.7,ECO:0000269|Ref.8;Dbxref=PMID:19413330,PMID:20068231,PMID:21406692,PMID:22223895,PMID:22814378,PMID:7993898	
Q00839	UniProtKB	Chain	2	825	.	.	.	ID=PRO_0000081872;Note=Heterogeneous nuclear ribonucleoprotein U	
Q00839	UniProtKB	Domain	8	42	.	.	.	Note=SAP;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00186,ECO:0000269|PubMed:11003645,ECO:0000269|PubMed:9405365;Dbxref=PMID:11003645,PMID:9405365	
Q00839	UniProtKB	Domain	267	464	.	.	.	Note=B30.2/SPRY;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00548	
Q00839	UniProtKB	Nucleotide binding	504	511	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q00839	UniProtKB	Region	488	672	.	.	.	Note=ATPase domain;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28622508;Dbxref=PMID:28622508	
Q00839	UniProtKB	Region	611	626	.	.	.	Note=Actin-binding;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15711563;Dbxref=PMID:15711563	
Q00839	UniProtKB	Region	714	739	.	.	.	Note=RNA-binding RGG-box;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14608463,ECO:0000269|PubMed:1628625;Dbxref=PMID:14608463,PMID:1628625	
Q00839	UniProtKB	Compositional bias	2	160	.	.	.	Note=Asp/Glu-rich (acidic)	
Q00839	UniProtKB	Compositional bias	84	94	.	.	.	Note=Poly-Glu	
Q00839	UniProtKB	Compositional bias	161	209	.	.	.	Note=Gln-rich	
Q00839	UniProtKB	Compositional bias	703	825	.	.	.	Note=Gly-rich	
Q00839	UniProtKB	Compositional bias	740	750	.	.	.	Note=Poly-Gly	
Q00839	UniProtKB	Site	100	101	.	.	.	Note=Cleavage%3B by CASP3;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10671544,ECO:0000269|PubMed:9405365;Dbxref=PMID:10671544,PMID:9405365	
Q00839	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine%3B partial;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:22223895,ECO:0000244|PubMed:22814378,ECO:0000269|Ref.7,ECO:0000269|Ref.8;Dbxref=PMID:19413330,PMID:20068231,PMID:21406692,PMID:22223895,PMID:22814378	
Q00839	UniProtKB	Modified residue	4	4	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163	
Q00839	UniProtKB	Modified residue	17	17	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	21	21	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	59	59	.	.	.	Note=Phosphoserine%3B by PLK1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:25986610;Dbxref=PMID:17081983,PMID:18220336,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569,PMID:25986610	
Q00839	UniProtKB	Modified residue	66	66	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18220336,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163	
Q00839	UniProtKB	Modified residue	186	186	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	187	187	.	.	.	Note=ADP-ribosylserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28190768;Dbxref=PMID:28190768	
Q00839	UniProtKB	Modified residue	255	255	.	.	.	Note=Citrulline;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	265	265	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q00839	UniProtKB	Modified residue	266	266	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	267	267	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q00839	UniProtKB	Modified residue	271	271	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:17487921,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:17081983,PMID:17487921,PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163,PMID:24275569	
Q00839	UniProtKB	Modified residue	286	286	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q00839	UniProtKB	Modified residue	352	352	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q00839	UniProtKB	Modified residue	516	516	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q00839	UniProtKB	Modified residue	524	524	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q00839	UniProtKB	Modified residue	532	532	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q00839	UniProtKB	Modified residue	551	551	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q00839	UniProtKB	Modified residue	565	565	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q00839	UniProtKB	Modified residue	582	582	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q00839	UniProtKB	Modified residue	635	635	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q00839	UniProtKB	Modified residue	702	702	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q00839	UniProtKB	Modified residue	715	715	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	720	720	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	727	727	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	733	733	.	.	.	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q00839	UniProtKB	Modified residue	733	733	.	.	.	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8VEK3	
Q00839	UniProtKB	Modified residue	739	739	.	.	.	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q00839	UniProtKB	Modified residue	739	739	.	.	.	Note=Dimethylated arginine%3B in A2780 ovarian carcinoma cell line;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8	
Q00839	UniProtKB	Modified residue	739	739	.	.	.	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q00839	UniProtKB	Modified residue	755	755	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q00839	UniProtKB	Modified residue	762	762	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q00839	UniProtKB	Modified residue	814	814	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q00839	UniProtKB	Cross-link	265	265	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25114211;Dbxref=PMID:25114211	
Q00839	UniProtKB	Cross-link	265	265	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25114211,ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25114211,PMID:25218447,PMID:28112733	
Q00839	UniProtKB	Cross-link	495	495	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	516	516	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	524	524	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	536	536	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	565	565	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	574	574	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	609	609	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
Q00839	UniProtKB	Cross-link	626	626	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	635	635	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	664	664	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Cross-link	670	670	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
Q00839	UniProtKB	Cross-link	814	814	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00839	UniProtKB	Alternative sequence	213	231	.	.	.	ID=VSP_005846;Note=In isoform 2. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:1628625,ECO:0000303|PubMed:7509195;Dbxref=PMID:15489334,PMID:1628625,PMID:7509195	
Q00839	UniProtKB	Natural variant	171	825	.	.	.	ID=VAR_078622;Note=In EIEE54. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25356899;Dbxref=PMID:25356899	
Q00839	UniProtKB	Natural variant	712	712	.	.	.	ID=VAR_014712;Note=F->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1628625,ECO:0000269|Ref.3;Dbxref=dbSNP:rs1052660,PMID:1628625	
Q00839	UniProtKB	Natural variant	805	825	.	.	.	ID=VAR_078623;Note=In EIEE54%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187	
Q00839	UniProtKB	Mutagenesis	59	59	.	.	.	Note=No change in interaction with AURKA%2C PLK1 and TPX2. Increases mitotic chromosome misalignment and chromosome segregation defects and time required to progress through mitosis. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17081983;Dbxref=PMID:17081983	
Q00839	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Increases mitotic chromosome misalignment and chromosome segregation defects and decreases time required to progress through mitosis. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17081983;Dbxref=PMID:17081983	
Q00839	UniProtKB	Mutagenesis	100	100	.	.	.	Note=No cleavage by caspases during apoptosis. Inhibits CASP3-induced cleavage in vitro. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10671544;Dbxref=PMID:10671544	
Q00839	UniProtKB	Mutagenesis	616	620	.	.	.	Note=Loss of actin-binding. RTQKK->ATQAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15711563;Dbxref=PMID:15711563	
Q00839	UniProtKB	Sequence conflict	603	603	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
